KAM
IPXL

Krensavage Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Krensavage Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,032,187
Closed -$24.5M – 18
2016
Q3 		$24.5M Buy
1,032,187
+301,370
+41% +$8.1M 8.84% 4
2016
Q2 		$21.1M Buy
730,817
+142,935
+24% +$4.66M 7.59% 3
2016
Q1 		$18.8M Buy
587,882
+2,712
+0.5% +$95.3K 6.75% 6
2015
Q4 		$25M Buy
585,170
+54,295
+10% +$2.17M 7.98% 6
2015
Q3 		$18.7M Buy
530,875
+75,400
+17% +$3.4M 6.77% 6
2015
Q2 		$20.9M Buy
455,475
+44,531
+11% +$2.11M 7.89% 3
2015
Q1 		$19.3M Sell
410,944
-12,217
-3% -$486K 8.77% 2
2014
Q4 		$13.4M Buy
+423,161
New +$12.4M 7.47% 4

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Krensavage Asset Management's IPXL Position: Q4 2016 in Review

Krensavage Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 1,032,187 shares — an estimated $24.5M sold.

Krensavage Asset Management first reported a position in IPXL in Q4 2014 and held it in 8 quarters. The position peaked at $25M in Q4 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Krensavage Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Krensavage Asset Management sold 1,032,187 Impax Laboratories, Inc. shares in Q4 2016, an estimated $24.5M.
  • Krensavage Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 8 quarters.
  • Krensavage Asset Management's Impax Laboratories, Inc. position peaked at $25M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Krensavage Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.